Sezary Syndrome

Showing 1 - 25 of 36

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

Recruiting
  • T-cell Lymphoma
  • +30 more
  • Optional Blood Sample
  • Optional Nail Sample
  • Duarte, California
  • +25 more
Jul 28, 2023

Mycosis Fungoides, Sezary Syndrome, Mycosis Fungoides/Sezary Syndrome Trial in Saint Louis (Tulmimetostat)

Not yet recruiting
  • Mycosis Fungoides
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 13, 2023

CTCL, Mycosis Fungoides, Sezary Syndrome Trial in New York (Ritlecitinib)

Recruiting
  • CTCL
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
May 18, 2023

Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

Recruiting
  • Adenoid Cystic Skin Carcinoma
  • +38 more
  • Biopsy
  • +6 more
  • Los Angeles, California
  • +35 more
Jan 31, 2023

T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

Not yet recruiting
  • T-Cell Non-Hodgkin Lymphoma
  • +14 more
  • WU-CART-007
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 17, 2023

Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides Trial in United

Recruiting
  • Folliculotropic Mycosis Fungoides
  • +7 more
  • Durvalumab
  • +2 more
  • Duarte, California
  • +3 more
Jan 12, 2023

Mycosis Fungoides, Recurrent Mycosis Fungoides, Recurrent Mycosis Fungoides and Sezary Syndrome Trial in United States

Recruiting
  • Mycosis Fungoides
  • +11 more
  • Biospecimen Collection
  • +5 more
  • Duarte, California
  • +12 more
Jan 7, 2023

Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

Completed
  • Adult T-Cell Lymphoma/Leukemia
  • +2 more
  • Recombinant human Interleukin-15 (rhIL-15)
  • Mogamulizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 9, 2022

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Worldwide (resminostat, Placebo)

Active, not recruiting
  • Mycosis Fungoides
  • +2 more
  • Graz, Austria
  • +53 more
Dec 12, 2022

Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,

Active, not recruiting
  • Folliculotropic Mycosis Fungoides
  • +7 more
  • Extracorporeal Photopheresis
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Peripheral T-Cell Lymphoma Trial in Columbus (Letermovir)

Recruiting
  • B-Cell Prolymphocytic Leukemia
  • +5 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 18, 2022

Mycosis Fungoides, Lymphomatoid Papulosis, Sezary Syndrome Trial in United States (brentuximab vedotin)

Recruiting
  • Mycosis Fungoides
  • +2 more
  • brentuximab vedotin
  • Stanford, California
  • +7 more
Nov 3, 2022

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Sézary Syndrome Trial in United States (Naloxone Hydrochloride Lotion, 0.5%,

Terminated
  • Mycosis Fungoides
  • +2 more
  • Naloxone Hydrochloride Lotion, 0.5%
  • Placebo Lotion
  • Little Rock, Arkansas
  • +15 more
Oct 26, 2022

Sezary Syndrome, Mycosis Fungoides Trial in Stanford (Mogamulizumab, LD TSEBT)

Recruiting
  • Sezary Syndrome
  • Mycosis Fungoides
  • Stanford, California
    Stanford Cancer Center
Oct 19, 2022

Extracorporeal Photopheresis in Sezary Syndrome

Recruiting
  • Sezary Syndrome
  • Extracorporeal photopheresis (ECP)
  • Methoxsalen Injection
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Aug 12, 2022

Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Stanford (anti-thymocyte globulin, cyclosporine, Lymphoid

Active, not recruiting
  • Mycoses
  • +5 more
  • anti-thymocyte globulin
  • +2 more
  • Stanford, California
    Stanford University School of Medicine
Jun 16, 2022

Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Atlanta (procedure, biological,

Recruiting
  • Mycosis Fungoides
  • +2 more
  • Extracorporeal Photopheresis
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital
Jun 15, 2022

Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Large B-Cell, Diffuse Trial in Spain (Registry of

Recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • Registry of patients (exposure is Cutaneous Lymphoma)
  • Barcelona, Spain
  • +13 more
Mar 15, 2022

Mycosis Fungoides, Sezary Syndrome, Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8 Trial in Jacksonville (Pembrolizumab)

Recruiting
  • Mycosis Fungoides
  • +12 more
  • Pembrolizumab
  • Jacksonville, Florida
    Mayo Clinic in Florida
Mar 22, 2022

Cutaneous T Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome Trial in Leeds ([14C]-resminostat)

Completed
  • Cutaneous T Cell Lymphoma
  • +2 more
  • Leeds, United Kingdom
    Covance Clinical research Unit Ltd.
Feb 3, 2022

SURvival of SEzary Syndrome Over 1998-2020 Period and Its

Not yet recruiting
  • Sezary Syndrome
  • Cutaneous T Lymphoma
  • Standard of care
  • Paris, France
    Hôpital Saint-Louis, Service de Dermatologie
Jan 24, 2022

Patients With Mycosis Fungoides and Sézary Syndrome.

Recruiting
  • Mycosis Fungoides
  • Sezary Syndrome
  • Blood tests and testing of analysis of the lymphoma microenvironment in skin, skin barrier and skin microbiology profile.
  • Lund, Sweden
    Lund University Hospital
May 21, 2021

Mycosis Fungoides, Sezary Syndrome Trial run by the NHLBI (A matched peripheral donor stem cells, cyclosporine, fludarabine)

Completed
  • Mycosis Fungoides
  • Sezary Syndrome
  • A matched peripheral donor stem cells
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2020

Mycosis Fungoides, Sézary Syndrome Trial in Richmond (TSEB Therapy, Brentuximab vedotin)

Completed
  • Mycosis Fungoides
  • Sézary Syndrome
  • TSEB Therapy
  • Brentuximab vedotin
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Aug 29, 2019

CD30-Positive Neoplastic Cells Present, Folliculotropic Mycosis Fungoides, Recurrent Mycosis Fungoides Trial in Duarte

Withdrawn
  • CD30-Positive Neoplastic Cells Present
  • +6 more
  • Brentuximab Vedotin
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Apr 26, 2019